PRESS RELEASE published on 11/04/2024 at 07:30, 2 years ago OSE Immunotherapeutics Announces Statistically Significant and Clinically Meaningful Results from the Phase 2 Study of Anti-IL7R mAb Lusvertikimab for the Treatment of Ulcerative Colitis OSE Immunotherapeutics reports positive results from Phase 2 study of Lusvertikimab for Ulcerative Colitis treatment. Primary endpoint met with high clinical and endoscopic remission rates Positive Results Phase 2 Study OSE Immunotherapeutics Lusvertikimab Ulcerative Colitis Treatment
REGULATED PRESS RELEASE published on 11/04/2024 at 07:29, 2 years ago Nouvelle direction de Schneider Electric : nomination d’Olivier Blum au poste de Directeur Général Schneider Electric nomme Olivier Blum au poste de Directeur Général pour accélérer sa stratégie de développement. Fin des fonctions de Peter Herweck Schneider Electric Directeur Général Développement Stratégique Olivier Blum Peter Herweck
REGULATED PRESS RELEASE published on 11/04/2024 at 07:29, 2 years ago Schneider Electric new leadership: Appointment of Olivier Blum as Chief Executive Officer Schneider Electric appoints Olivier Blum as Chief Executive Officer to drive strategic execution and development phase, succeeding Peter Herweck. Company aims for focused acceleration Schneider Electric Strategy Chief Executive Officer Olivier Blum Acceleration
PRESS RELEASE published on 11/04/2024 at 07:25, 2 years ago SUSS MicroTec signs long-term lease agreement for new production site in Taiwan SUSS MicroTec signs long-term lease agreement for new production site in Taiwan, doubling production capacity to meet high demand for semiconductor solutions Semiconductor Industry Capacity Expansion SÜSS MicroTec Taïwan Production Site
PRESS RELEASE published on 11/04/2024 at 07:00, 2 years ago Relief Therapeutics Signs Non-Binding Letter of Intent with Renexxion for Reverse Merger Relief Therapeutics signs non-binding letter of intent with Renexxion for reverse merger, aiming to create a combined entity with an expanded therapeutic pipeline Biopharmaceutical Relief Therapeutics Therapeutic Pipeline Reverse Merger Renexxion
PRESS RELEASE published on 11/04/2024 at 06:56, 2 years ago EQS-Adhoc: Brockhaus Technologies AG: High profitability and organic growth in 9M 2024; revenue increases by +22.9% to €175m and adj. EBITDA by +25.0% to €68m (38.8% margin) – 2024 forecast confirmed Brockhaus Technologies AG reports high profitability and organic growth in 9M 2024, with revenue up by +22.9% to €175m and adj. EBITDA by +25.0% to €68m. Forecast for 2024 confirmed Revenue Growth Forecast EBITDA Increase Brockhaus Technologies AG 9M 2024
PRESS RELEASE published on 11/04/2024 at 06:30, 2 years ago Formycon applies for admission to the Prime Standard of the Frankfurt Stock Exchange Formycon AG applies for admission to the Prime Standard of the Frankfurt Stock Exchange to enhance international visibility and investor base Frankfurt Stock Exchange Formycon AG Uplisting Admission Prime Standard
PRESS RELEASE published on 11/04/2024 at 06:00, 2 years ago NanoViricides to Provide Corporate Update at the Spartan Capital Investors Conference 2024, Today at 9:45am NanoViricides, Inc. to present corporate update at Spartan Capital Investors Conference on NV-387 antiviral drug development with strong market potential NV-387 NanoViricides Inc. Market Potential Antiviral Drug Spartan Capital Investors Conference
PRESS RELEASE published on 11/04/2024 at 06:00, 2 years ago Faraday Copper Reports Third Quarter 2024 Financial Results Faraday Copper Corp. announces financial results for the three months ended September 30, 2024, highlighting high-grade copper discoveries and ongoing exploration at the Copper Creek Project Financial Results Exploration Faraday Copper Corp. Copper Creek Project High-grade Copper
PRESS RELEASE published on 11/04/2024 at 03:00, 2 years ago OPPO and HKPolyU Renew Collaboration and Launch Joint Innovation Research Centre to Expand AI Imaging Frontiers OPPO and PolyU deepen collaboration to upgrade Joint Innovation Research Centre, enhancing AI imaging technology. Signing ceremony held at PolyU campus Collaboration OPPO AI Imaging Technology PolyU Joint Innovation Research Centre
Published on 11/20/2026 at 14:50, 27 minutes ago Proposed Issue Of Payment-In-Kind Interest Shares Under Convertible Debenture
Published on 11/20/2026 at 14:00, 1 hour 17 minutes ago Dateline appoints Tony Ferguson as Acting Chairman
Published on 11/20/2026 at 13:30, 1 hour 47 minutes ago Collective Metals Enters Into Option to Acquire the Lac Tio West Property in Quebec
Published on 11/20/2026 at 13:30, 1 hour 47 minutes ago Alset AI Closes Non-Brokered Private Placement Offering
Published on 11/20/2026 at 15:03, 13 minutes ago Form 8.3 - The Vanguard Group, Inc.: Tate & Lyle PLC
Published on 11/20/2026 at 15:02, 15 minutes ago Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group PLC
Published on 11/19/2026 at 19:00, 20 hours 17 minutes ago MR.BRICOLAGE: OUTLOOK FOR THE 2026 FINANCIAL YEAR
Published on 11/19/2026 at 19:00, 20 hours 17 minutes ago MR.BRICOLAGE : PERSPECTIVES POUR L'EXERCICE 2026
Published on 11/19/2026 at 08:30, 1 day 6 hours ago Data sovereignty: Cegedim opens EB6, a next-generation datacenter for AI and high-density computing
Published on 11/19/2026 at 08:30, 1 day 6 hours ago Souveraineté des données : Cegedim ouvre EB6, un datacenter nouvelle génération pour l'IA et la haute densité